These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 24861254)

  • 41. Clinical research in Hungary. Infrastructure, organisation, legislation and framework. The situation in 2008.
    Blaskó G; Kardos G
    Therapie; 2009; 64(1):33-45. PubMed ID: 19463251
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
    Peña C; Bowsher K; Costello A; De Luca R; Doll S; Li K; Schroeder M; Stevens T
    IEEE Trans Neural Syst Rehabil Eng; 2007 Sep; 15(3):421-4. PubMed ID: 17894274
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Medical Device Approvals Through the Premarket Approval Pathway in Obstetrics and Gynecology From 2000 to 2015: Process and Problems.
    Walter JR; Hayman E; Tsai S; Ghobadi CW; Xu S
    Obstet Gynecol; 2016 Jun; 127(6):1110-1117. PubMed ID: 27159747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The nightmare of FDA clearance/approval to market: perception or reality?
    Tylenda CA
    Technol Health Care; 1996 Sep; 4(3):259-67. PubMed ID: 8931236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Generating appropriate clinical data for value assessment of medical devices: what role does regulation play?
    Tarricone R; Torbica A; Ferré F; Drummond M
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):707-18. PubMed ID: 25196848
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An evaluation of a distributed medical device safety surveillance system: the DELTA network study.
    Vidi VD; Matheny ME; Donnelly S; Resnic FS
    Contemp Clin Trials; 2011 May; 32(3):309-17. PubMed ID: 21356331
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and tolerability of almotriptan in postmarketing surveillance studies.
    Pascual J
    Eur Neurol; 2005; 53 Suppl 1():34-40. PubMed ID: 15920336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Premarket evaluation of medical devices: a cross-sectional analysis of clinical studies submitted to a German ethics committee.
    Sauerland S; Fujita-Rohwerder N; Zens Y; Molnar S
    BMJ Open; 2019 Feb; 9(2):e027041. PubMed ID: 30798319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality and transparency of evidence for implantable cardiovascular medical devices assessed by the CORE-MD consortium.
    Siontis GCM; Coles B; Häner JD; McGovern L; Bartkowiak J; Coughlan JJ; Spirito A; Galea R; Haeberlin A; Praz F; Tomii D; Melvin T; Frenk A; Byrne RA; Fraser AG; Windecker S;
    Eur Heart J; 2024 Jan; 45(3):161-177. PubMed ID: 37638967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Device regulation and surveillance in vascular care: Challenges and opportunities.
    Pyun AJ; Goodney PP; Eldrup-Jorgensen J; Wadzinski J; Secemsky EA; Cigarroa JE
    Catheter Cardiovasc Interv; 2024 Jul; 104(1):84-91. PubMed ID: 38639136
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pre-market approval and post-market direct-to-consumer advertising of medical devices in Australia: a case study of breast cancer screening and diagnostic devices.
    Vreugdenburg TD; Willis CD; Mundy L; Hiller JE
    Intern Med J; 2013 Jan; 43(1):53-8. PubMed ID: 22032398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Utilizing national and international registries to enhance pre-market medical device regulatory evaluation.
    Yue LQ; Campbell G; Lu N; Xu Y; Zuckerman B
    J Biopharm Stat; 2016; 26(6):1136-1145. PubMed ID: 27540636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Integrating the patient's perspective into device evaluation trials.
    Leidy NK; Beusterien K; Sullivan E; Richner R; Muni NI
    Value Health; 2006; 9(6):394-401. PubMed ID: 17076870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IDEAL-D: a rational framework for evaluating and regulating the use of medical devices.
    Sedrakyan A; Campbell B; Merino JG; Kuntz R; Hirst A; McCulloch P
    BMJ; 2016 Jun; 353():i2372. PubMed ID: 27283585
    [No Abstract]   [Full Text] [Related]  

  • 55. Contemporary cardiovascular device clinical trials (trends and patterns 2001 to 2012).
    Vaduganathan M; Tahhan AS; Greene SJ; Kelkar AA; Georgiopoulou VV; Kalogeropoulos AP; Fonarow GC; Gheorghiade M; Butler J
    Am J Cardiol; 2015 Jul; 116(2):307-12. PubMed ID: 25963222
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Comparative Study of Medical Device Regulations:: US, Europe, Canada, and Taiwan.
    Chen YJ; Chiou CM; Huang YW; Tu PW; Lee YC; Chien CH
    Ther Innov Regul Sci; 2018 Jan; 52(1):62-69. PubMed ID: 29714608
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Role of patient safety in the official approval of new surgical techniques and devices].
    Baranyai Z; Jósa V; Kulin L
    Orv Hetil; 2011 Dec; 152(52):2091-5. PubMed ID: 22155517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [New Medical Device Evaluation].
    Ikeda K
    Yakugaku Zasshi; 2016; 136(4):527-30. PubMed ID: 27040333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Methods for observational post-licensure medical product safety surveillance.
    Nelson JC; Cook AJ; Yu O; Zhao S; Jackson LA; Psaty BM
    Stat Methods Med Res; 2015 Apr; 24(2):177-93. PubMed ID: 22138688
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of endpoint adjudication to improve the quality and validity of endpoint assessment for medical device development and post marketing evaluation: Rationale and best practices. A report from the cardiac safety research consortium.
    Seltzer JH; Heise T; Carson P; Canos D; Hiatt JC; Vranckx P; Christen T; Cutlip DE
    Am Heart J; 2017 Aug; 190():76-85. PubMed ID: 28760216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.